Cart
sales@molnova.com
CpCDPK1/TgCDPK1-IN-2
CAS No. 1236038-23-5
CpCDPK1/TgCDPK1-IN-2( —— )
Catalog No. M36439 CAS No. 1236038-23-5
CpCDPK1/TgCDPK1-IN-2 is a dual inhibitor of CpCDPK1 and TgCDPK1 with IC50 values of 12 and 5 nM for CpCDPK1 and TgCDPK1, respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 331 | In Stock |
|
| 10MG | 451 | In Stock |
|
| 25MG | 634 | In Stock |
|
| 50MG | 825 | In Stock |
|
| 100MG | 1135 | In Stock |
|
| 200MG | 1516 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCpCDPK1/TgCDPK1-IN-2
-
NoteResearch use only, not for human use.
-
Brief DescriptionCpCDPK1/TgCDPK1-IN-2 is a dual inhibitor of CpCDPK1 and TgCDPK1 with IC50 values of 12 and 5 nM for CpCDPK1 and TgCDPK1, respectively.
-
DescriptionCpCDPK1/TgCDPK1-IN-2 (Compound 7r) is a CpCDPK1 and TgCDPK1 inhibitor with IC50 values of 12 and 5 nM, respectively. CpCDPK1/TgCDPK1-IN-2 can be used in the research of apicomplexan protozoa-related diseases, such as the research of T. gondii, C. parvum and C. hominus infection.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMicrobiology/Virology
-
TargetParasite
-
RecptorParasite
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1236038-23-5
-
Formula Weight347.41
-
Molecular FormulaC20H21N5O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESNC1=C2C(=NN(C(C)C)C2=NC=N1)C3=CC4=C(C=C3)C=C(OCC)C=C4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Wesley C. Van Voorhis, et al. Compositions And Methods For Treating Toxoplasmosis, Cryptosporidiosis, And Other Apicomplexan Protozoan Related Diseases. US20130018040A1.
molnova catalog
related products
-
Emodepside
A semisynthetic derivative of PF1022A, and novel cyclo-depsipeptide anthelmintic which is efficacious against a variety of gastrointestinal nematodes.
-
Tafenoquine succinat...
Tafenoquine succinate (SB-252263, Tafenoquine, WR 238605) is a long-acting, orally active anti-malarial agent to prevent malaria that is holoendemic for Plasmodium falciparum.
-
ZY-19489
ZY-19489 is an antimalarial compound that is a potential single-dose cure for Plasmodium falciparum and Plasmodium vivax malaria. It has received orphan drug designation from the FDA.
